Phase 1 Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who are able to give written consent to participate, and who are able to follow the study requirements
- People who have a good general level of functioning, as measured by a standard medical scale called the Karnofsky Performance Scale (score above 70) (confirm with trial site)
- People who have a suspected, newly diagnosed, or returning brain tumour that is likely to be a specific type called IDH wild-type WHO Grade IV glioblastoma, based on brain imaging reviewed by a specialist radiology team
Who may not be able to join:
- People under 18 years of age
- People who have a health condition or abnormality that the study doctor believes could put them at risk or affect the reliability of the study results
- People who are not medically cleared to undergo open brain surgery (specifically a procedure to remove a tumour, not just a biopsy), based on standard pre-surgical guidelines
- People whose tumour is located in, or clearly affecting, certain critical areas of the brain — including areas that control movement, sensation, language (such as Broca's and Wernicke's areas), or the nerve fibres connecting these areas, as identified on specialised brain scans
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Resection limiting toxicities
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.